AIP
VOR icon

Ameritas Investment Partners’s Vor Biopharma VOR Stock Holding History

Ameritas Investment Partners’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-156
Closed -$7.37K – 3238
2024
Q1 		$7.37K Hold
156
– – ﹤0.01% 2891
2023
Q4 		$7K Hold
156
– – ﹤0.01% 2922
2023
Q3 		$6.59K Hold
156
– – ﹤0.01% 2938
2023
Q2 		$9.61K Buy
+156
New +$14.2K ﹤0.01% 2919
2022
Q2 		– Sell
-74
Closed -$9K – 3245
2022
Q1 		$9K Hold
74
– – ﹤0.01% 2840
2021
Q4 		$17K Hold
74
– – ﹤0.01% 2719
2021
Q3 		$23K Buy
74
+28
+61% +$8.32K ﹤0.01% 2630
2021
Q2 		$17K Hold
46
– – ﹤0.01% 2824
2021
Q1 		$40K Buy
+46
New +$38.9K ﹤0.01% 2216

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameritas Investment Partners's VOR Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Vor Biopharma (VOR) in Q2 2024, closing a stake of 156 shares — an estimated $7.37K sold.

Ameritas Investment Partners first reported a position in VOR in Q1 2021 and held it in 9 quarters. The position peaked at $40K in Q1 2021. 71 funds tracked by Wall St. Rank hold VOR as of Q2 2024.

  • Ameritas Investment Partners reported no remaining Vor Biopharma position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 156 Vor Biopharma shares in Q2 2024, an estimated $7.37K.
  • Ameritas Investment Partners first reported a position in Vor Biopharma in Q1 2021 and held it in 9 quarters.
  • Ameritas Investment Partners's Vor Biopharma position peaked at $40K in Q1 2021.
  • 71 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.